The import of opacifying preparations, X-ray, and diagnostic reagents to India has demonstrated an overall growth trajectory over the last decade but has experienced occasional fluctuations. From 2013 to 2023, imports increased from $34.627 million to $47.885 million, indicating a rising trend with occasional drops, notably in 2014 and a slight dip in 2016 and 2022. The CAGR over the last five years was 3.66%, reflecting moderate but consistent growth.
Over the past two years, the year-on-year growth rate showed significant variations: • In 2022, there was a slight decline of 1.01%. • In 2023, there was a recovery with an increase of 3.71%.
Looking ahead, the forecast indicates steady growth with a CAGR of 2.41% over the next five years, expecting the import value to reach $56.05 million by 2028.
Future trends to watch for include potential advancements in medical technology and diagnostic methodologies, which could drive further demand for these reagents. Monitoring regulatory changes and trade policies related to medical imports will also be crucial.
